In this issue:
Clonal hematopoiesis in the donor’s effect on long-term outcomes post-HSCT
Post-transplantation cyclophosphamide based GVHD
Allogenic HSCT for NK/T-cell lymphoma
Matched related vs unrelated vs haploidentical donors for allogenic transplantation in AML
Cognitive functioning in survivors of HSCT
Impact of chronic GVHD on patient’s lifestyle
Please login below to download this issue (PDF)